#Italy #Menarini Group #Lomagna #STEP Seal #Lusochimica S.p.A

Lusochimica S.p.A. Receives STEP Seal Award from the European Commission

Lusochimica S.p.A., a member of the Menarini Group, has proudly announced its receipt of the esteemed STEP Seal award from the European Commission. This distinction recognizes projects that demonstrate outstanding potential in the realm of clean technologies. The STEP Seal specifically honors Lusochimica for its innovative initiative, SmartNEBI, aimed at making the synthesis of nebivolol more sustainable and environmentally friendly.

Emphasis on Sustainability and Efficiency

The SmartNEBI project represents a significant leap in pharmaceutical synthesis methodologies. By leveraging synergistic biocatalysis, which employs enzymes as biological catalysts for precise and efficient chemical transformations, alongside flow chemistry techniques, Lusochimica aims to optimize the synthesis process of nebivolol. This innovative combination enhances operational efficiency and safety, leading to improved heat and mass transfer during production.

By implementing these advanced methods, Lusochimica is set to produce nebivolol more productively, sustainably, and scalability. The environmental benefits are notable, particularly regarding reduced energy consumption and a smaller ecological footprint.

Roberto Falorni, Managing Director of Lusochimica S.p.A., expressed his pride in receiving the STEP Seal, emphasizing the recognition as a testament to the Menarini Group's commitment to driving innovation within the pharmaceutical industry: "This award confirms our dedication to research and developing groundbreaking solutions that can elevate our production processes and serve the needs of our patients more effectively."

Key Benefits of SmartNEBI

The implications of the SmartNEBI initiative are profound. By optimizing the synthesis of nebivolol—a crucial active pharmaceutical ingredient (API) for cardiovascular treatments—the project reduces dependency on harmful solvents and minimizes energy use. This not only can lead to better compliance with international sustainability guidelines but also fortifies the resilience of the global nebivolol supply chain crucial for millions of patients worldwide.

Furthermore, Lusochimica's dedication to producing high-quality APIs while adhering to strict international cGMP standards bolsters its position as a leading player in the pharmaceutical manufacturing landscape.

Lusochimica operates out of three facilities across Italy, including Lomagna, Pisa, and Casaletto Lodigiano, where it focuses on the synthesis of APIs and develops scalable manufacturing processes. This strategic approach enables Lusochimica to thrive in an increasingly competitive market while maintaining its commitment to environmentally responsible production methods.

About Lusochimica S.p.A. and Menarini Group

Founded as an integral part of the Menarini Group, Lusochimica S.p.A. specializes in manufacturing APIs and has built a reputation for reliability and excellence in pharmaceutical production. Menarini Group itself is a prominent pharmaceutical and diagnostics company based in Florence, Italy, with operations spanning over 140 countries. The group generates approximately €4.6 billion in revenue and employs more than 17,000 professionals, highlighting its influence across multiple therapeutic areas such as cardiology, oncology, and infectious diseases.

With a strong focus on research and development, Menarini Group invests significantly in new therapies while producing over 609 million packages of medications each year across various continents.

Conclusion

The STEP Seal awarded to Lusochimica not only underscores the company’s commitment to innovation and ecological sustainability but also highlights a crucial step in transforming the pharmaceutical landscape towards greener practices. As the industry continues to evolve, Lusochimica S.p.A., backed by Menarini Group's strong ethos of quality and sustainability, is poised to lead the charge in responsible pharmaceutical manufacturing.